Corrigendum to 'Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials': [ESMO Open Volume 7, Issue 2, (2022), 100455]

Subjects

Subjects :

10255 Clinic for Thoracic Surgery
2730 Oncology
1306 Cancer Research
610 Medicine & health
10044 Clinic for Radiation Oncology

Details

Database :

OpenAIRE

Journal :

K&#246;nig, D; Sch&#228;r, S; Vuong, D; Guckenberger, M; Furrer, K; Opitz, I; Weder, W; Rothschild, S I; Ochsenbein, A; Zippelius, A; Addeo, A; Mark, M; Eboulet, E I; Hayoz, S; Thierstein, S; Betticher, D C; Ris, H-B; Stupp, R; Curioni-Fontecedro, A; Peters, S; ... (2022). Corrigendum to &#39;Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials&#39;: [ESMO Open Volume 7, Issue 2, (2022), 100455]. ESMO open, 7(3), p. 100494. Elsevier 10.1016/j.esmoop.2022.100494 <http://dx.doi.org/10.1016/j.esmoop.2022.100494>

Accession number :

edsair.doi.dedup.....7b7758c5e0f3b2ce34c3c65c55ccb36d

Full Text :

https://doi.org/10.5167/uzh-220870